Modelling the COVID-19 pandemic in context : an international participatory approach
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ..
The SARS-CoV-2 pandemic has had an unprecedented impact on multiple levels of society. Not only has the pandemic completely overwhelmed some health systems but it has also changed how scientific evidence is shared and increased the pace at which such evidence is published and consumed, by scientists, policymakers and the wider public. More significantly, the pandemic has created tremendous challenges for decision-makers, who have had to implement highly disruptive containment measures with very little empirical scientific evidence to support their decision-making process. Given this lack of data, predictive mathematical models have played an increasingly prominent role. In high-income countries, there is a long-standing history of established research groups advising policymakers, whereas a general lack of translational capacity has meant that mathematical models frequently remain inaccessible to policymakers in low-income and middle-income countries. Here, we describe a participatory approach to modelling that aims to circumvent this gap. Our approach involved the creation of an international group of infectious disease modellers and other public health experts, which culminated in the establishment of the COVID-19 Modelling (CoMo) Consortium. Here, we describe how the consortium was formed, the way it functions, the mathematical model used and, crucially, the high degree of engagement fostered between CoMo Consortium members and their respective local policymakers and ministries of health.
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:5 |
|---|---|
| Enthalten in: |
BMJ global health - 5(2020), 12 vom: 23. Dez. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Aguas, Ricardo [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Control strategies |
|---|
| Anmerkungen: |
Date Completed 11.01.2021 Date Revised 06.02.2021 published: Print ErratumIn: BMJ Glob Health. 2021 Feb;6(2):. - PMID 33547179 Citation Status MEDLINE |
|---|
| doi: |
10.1136/bmjgh-2020-003126 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM31925514X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM31925514X | ||
| 003 | DE-627 | ||
| 005 | 20231225171051.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/bmjgh-2020-003126 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1064.xml |
| 035 | |a (DE-627)NLM31925514X | ||
| 035 | |a (NLM)33361188 | ||
| 035 | |a (PII)e003126 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Aguas, Ricardo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Modelling the COVID-19 pandemic in context |b an international participatory approach |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.01.2021 | ||
| 500 | |a Date Revised 06.02.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a ErratumIn: BMJ Glob Health. 2021 Feb;6(2):. - PMID 33547179 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. | ||
| 520 | |a The SARS-CoV-2 pandemic has had an unprecedented impact on multiple levels of society. Not only has the pandemic completely overwhelmed some health systems but it has also changed how scientific evidence is shared and increased the pace at which such evidence is published and consumed, by scientists, policymakers and the wider public. More significantly, the pandemic has created tremendous challenges for decision-makers, who have had to implement highly disruptive containment measures with very little empirical scientific evidence to support their decision-making process. Given this lack of data, predictive mathematical models have played an increasingly prominent role. In high-income countries, there is a long-standing history of established research groups advising policymakers, whereas a general lack of translational capacity has meant that mathematical models frequently remain inaccessible to policymakers in low-income and middle-income countries. Here, we describe a participatory approach to modelling that aims to circumvent this gap. Our approach involved the creation of an international group of infectious disease modellers and other public health experts, which culminated in the establishment of the COVID-19 Modelling (CoMo) Consortium. Here, we describe how the consortium was formed, the way it functions, the mathematical model used and, crucially, the high degree of engagement fostered between CoMo Consortium members and their respective local policymakers and ministries of health | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a SARS | |
| 650 | 4 | |a control strategies | |
| 650 | 4 | |a health policy | |
| 650 | 4 | |a respiratory infections | |
| 700 | 1 | |a White, Lisa |e verfasserin |4 aut | |
| 700 | 1 | |a Hupert, Nathaniel |e verfasserin |4 aut | |
| 700 | 1 | |a Shretta, Rima |e verfasserin |4 aut | |
| 700 | 1 | |a Pan-Ngum, Wirichada |e verfasserin |4 aut | |
| 700 | 1 | |a Celhay, Olivier |e verfasserin |4 aut | |
| 700 | 1 | |a Moldokmatova, Ainura |e verfasserin |4 aut | |
| 700 | 1 | |a Arifi, Fatima |e verfasserin |4 aut | |
| 700 | 1 | |a Mirzazadeh, Ali |e verfasserin |4 aut | |
| 700 | 1 | |a Sharifi, Hamid |e verfasserin |4 aut | |
| 700 | 1 | |a Adib, Keyrellous |e verfasserin |4 aut | |
| 700 | 1 | |a Sahak, Mohammad Nadir |e verfasserin |4 aut | |
| 700 | 1 | |a Franco, Caroline |e verfasserin |4 aut | |
| 700 | 1 | |a Coutinho, Renato |e verfasserin |4 aut | |
| 700 | 0 | |a CoMo Consortium |e verfasserin |4 aut | |
| 700 | 1 | |a Ariana, Proochista |e investigator |4 oth | |
| 700 | 1 | |a Hancock, Penny |e investigator |4 oth | |
| 700 | 1 | |a Kraenkel, Roberto A |e investigator |4 oth | |
| 700 | 1 | |a Saralamba, Sompob |e investigator |4 oth | |
| 700 | 1 | |a Luangasanatip, Nantasit |e investigator |4 oth | |
| 700 | 1 | |a Silal, Sheetal Prakash |e investigator |4 oth | |
| 700 | 1 | |a Norman, Jared |e investigator |4 oth | |
| 700 | 1 | |a Hounsell, Rachel |e investigator |4 oth | |
| 700 | 1 | |a Tun, Sai |e investigator |4 oth | |
| 700 | 1 | |a Aung, Yu Nandar |e investigator |4 oth | |
| 700 | 1 | |a Bakare Emmanuel, A |e investigator |4 oth | |
| 700 | 1 | |a Getachew, Biniam |e investigator |4 oth | |
| 700 | 1 | |a Adele, Sandra |e investigator |4 oth | |
| 700 | 1 | |a Omoleke, Semeeh A |e investigator |4 oth | |
| 700 | 1 | |a Zaman, Rashid U |e investigator |4 oth | |
| 700 | 1 | |a Letchford, Nicholas |e investigator |4 oth | |
| 700 | 1 | |a Parker, Daniel M |e investigator |4 oth | |
| 700 | 1 | |a Pokharel, Sunil |e investigator |4 oth | |
| 700 | 1 | |a Lata, Dipti |e investigator |4 oth | |
| 700 | 1 | |a Chen, Siyu |e investigator |4 oth | |
| 700 | 1 | |a Kyaw, Shwe Sin |e investigator |4 oth | |
| 700 | 1 | |a Lubis, Inke N D |e investigator |4 oth | |
| 700 | 1 | |a Alona, Ivana |e investigator |4 oth | |
| 700 | 1 | |a Medina, John Robert C |e investigator |4 oth | |
| 700 | 1 | |a Mercado, Chris Erwin G |e investigator |4 oth | |
| 700 | 1 | |a Eybpoosh, Sana |e investigator |4 oth | |
| 700 | 1 | |a Mamadu, Ibrahim |e investigator |4 oth | |
| 700 | 1 | |a Marzouk, Manar |e investigator |4 oth | |
| 700 | 1 | |a Colombi, Nicole Feune de |e investigator |4 oth | |
| 700 | 1 | |a Suárez-Idueta, Lorena |e investigator |4 oth | |
| 700 | 1 | |a Obando, Francisco |e investigator |4 oth | |
| 700 | 1 | |a Freitas, Luzia |e investigator |4 oth | |
| 700 | 1 | |a Klein, Michael G |e investigator |4 oth | |
| 700 | 1 | |a Scales, David |e investigator |4 oth | |
| 700 | 1 | |a Aizhan, Dooronbekova |e investigator |4 oth | |
| 700 | 1 | |a Zhumalieva, Chynar |e investigator |4 oth | |
| 700 | 1 | |a Estebesova, Aida |e investigator |4 oth | |
| 700 | 1 | |a Mukambetov, Aibek |e investigator |4 oth | |
| 700 | 1 | |a Ibragimov, Shamil |e investigator |4 oth | |
| 700 | 1 | |a Kubatova, Aisuluu |e investigator |4 oth | |
| 700 | 1 | |a Chanthavialy, Phetsavanh |e investigator |4 oth | |
| 700 | 1 | |a Salim, Amel H |e investigator |4 oth | |
| 700 | 1 | |a Venkatesan, Sudhir |e investigator |4 oth | |
| 700 | 1 | |a Sarin, K C |e investigator |4 oth | |
| 700 | 1 | |a Shrestha, Priyanka |e investigator |4 oth | |
| 700 | 1 | |a Saeedzai, Sayed Ataullah |e investigator |4 oth | |
| 700 | 1 | |a Hsieh, Jenny |e investigator |4 oth | |
| 700 | 1 | |a Soukavong, Mick |e investigator |4 oth | |
| 700 | 1 | |a Yunanda, Yuki |e investigator |4 oth | |
| 700 | 1 | |a Harsono, Handoyo |e investigator |4 oth | |
| 700 | 1 | |a Fariba, Mahnaz Hossain |e investigator |4 oth | |
| 700 | 1 | |a Mabombo, Viviana |e investigator |4 oth | |
| 700 | 1 | |a Advani, Nicole |e investigator |4 oth | |
| 700 | 1 | |a Jabin, Nusrat |e investigator |4 oth | |
| 700 | 1 | |a Naidoo, Reshania |e investigator |4 oth | |
| 700 | 1 | |a Wattanasri, Parinda |e investigator |4 oth | |
| 700 | 1 | |a Nwosu, Amen-Patrick |e investigator |4 oth | |
| 700 | 1 | |a Obiesie, Sopuruchukwu |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t BMJ global health |d 2016 |g 5(2020), 12 vom: 23. Dez. |w (DE-627)NLM262254549 |x 2059-7908 |7 nnns |
| 773 | 1 | 8 | |g volume:5 |g year:2020 |g number:12 |g day:23 |g month:12 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/bmjgh-2020-003126 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 5 |j 2020 |e 12 |b 23 |c 12 | ||